𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Calgevax — a BCG preparation for immunotherapy of cancer

✍ Scribed by A. Engibarov; M. Chouchkova; G. Guencheva; Ch. Koychev

Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
74 KB
Volume
10
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Septic arthritis: A complication of BCG
Septic arthritis: A complication of BCG immunotherapy
✍ Jacob J. Lokich; Michael A. Drew 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

A new complication of cutaneous vaccination for immune therapy is reported: non-acid-fast bacteremia with metastatic septic arthritis. Systemic antibiotics should be administered prophylactically in patients with signs and symptoms of local infection, particularly in the presence of orthopedic prost

Postoperative adjuvant immunotherapy of
Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton
✍ Takenori Ochiai; Hiroshi Sato; Ryoichi Hayashi; Takehide Asano; Hirotoshi Sato; 📂 Article 📅 1983 🏛 Springer-Verlag 🌐 English ⚖ 386 KB

The clinical effectiveness of immunotherapy with the cell wall skeleton of Bacillus Calmette-Guérin was assessed in a study involving 140 consecutive patients with gastric cancer, who were gastrectomized at a single institution from January 1976 through December 1978. These patients were randomized

BCG immunotherapy of bladder cancer: Inh
BCG immunotherapy of bladder cancer: Inhibition of tumor recurrence and associated immune responses
✍ Donald L. Lamm; Daniel E. Thor; Wendell D. Winters; Valerie D. Stogdill; Howard 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Fifty-one patients with confirmed bladder cancer have enrolled in a prospective evaluation of BCG immunotherapy. Following resection of existing tumors, patients were stratified according to tumor grade and number of previous recurrences and randomly assigned to control or BCG treatment groups. Immu